表紙:ヘルスケアアナリティクスの世界市場 (~2026年):タイプ (記述的・処方的・コグニティブ)・用途 (財務・運営・RCM・不正管理・臨床)・コンポーネント (サービス・ハードウェア)・展開区分 (オンプレミス・クラウド)・エンドユーザー・地域別
市場調査レポート
商品コード
1028012

ヘルスケアアナリティクスの世界市場 (~2026年):タイプ (記述的・処方的・コグニティブ)・用途 (財務・運営・RCM・不正管理・臨床)・コンポーネント (サービス・ハードウェア)・展開区分 (オンプレミス・クラウド)・エンドユーザー・地域別

Healthcare Analytics Market by Type (Descriptive, Prescriptive, Cognitive), Application (Financial, Operational, RCM, Fraud, Clinical), Component (Services, Hardware), Deployment (On-premise, Cloud), End-user - Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 273 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円
ヘルスケアアナリティクスの世界市場 (~2026年):タイプ (記述的・処方的・コグニティブ)・用途 (財務・運営・RCM・不正管理・臨床)・コンポーネント (サービス・ハードウェア)・展開区分 (オンプレミス・クラウド)・エンドユーザー・地域別
出版日: 2021年09月08日
発行: MarketsandMarkets
ページ情報: 英文 273 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のヘルスケアアナリティクスの市場規模は予測期間中28.9%のCAGRで推移し、2021年の211億米ドルから、2026年には751億米ドルの規模に成長すると予測されています。ヘルスケアアナリティクスツールは、過去のデータパターンから、将来を予測し、実用的な洞察を提供することで、事実に基づく意思決定を促し、医療機関の臨床、財務、運営のパフォーマンスを向上させます。アナリティクスを活用することで、医療機関は医療費を削減し、医療の質を向上させることができます。一方で、ソフトウェアおよびサービスの高額な費用や、熟練した専門家の不足などが今後数年の市場成長の課題となる見通しです。

タイプ別で見ると、コグニティブアナリティクスの部門が最速の成長を示すと予測されています。

コグニティブアナリティクスは、機械学習、深層学習、自然言語処理(NLP)、推論・論理システムなどのAI技術を用いて分析を行います。一方、2021年の市場では、記述的アナリティクスの部門が52.3%で最大のシェアを示す見通しです。

当レポートでは、世界のヘルスケアアナリティクスの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、タイプ・コンポーネント・展開区分・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題

第6章 市場分析・予測:タイプ別

  • 記述的アナリティクス
  • 予測的アナリティクス
  • 処方的アナリティクス
  • コグニティブアナリティクス

第7章 市場分析・予測:コンポーネント別

  • サービス
    • サポートサービス
    • ビジネスアナリティクスサービス
  • ソフトウェア
  • ハードウェア

第8章 市場分析・予測:展開区分別

  • オンプレミス
  • オンデマンド

第9章 市場分析・予測:用途別

  • 財務アナリティクス
    • 請求処理
    • 収益サイクル管理
    • 決済の整合性・不正・浪費・誤用
    • リスク調整・評価
  • 臨床アナリティクス
    • 品質改善・臨床ベンチマーク
    • 臨床意思決定支援
    • レポー手ジング・とコンプライアンス
    • 比較アナリティクス・有効性
    • 精密ヘルス
    • 医用画像アナリティクス
  • 運用・管理アナリティクス
    • サプライチェーンアナリティクス
    • 労働力アナリティクス
    • 戦略的アナリティクス
  • 公衆衛生アナリティクス

第10章 市場分析・予測:エンドユーザー別

  • 保険者
    • 民間保険企業
    • 政府機関
    • 雇用者・プライベートエクスチェンジ
  • 医療提供者
    • 病院・診療所・IDN
    • 急性期後ケア組織(PACOS)
    • 外来診療
  • ACO・HIE・MCO・TPA

第11章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア
  • 太平洋諸国
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • 主要企業の成功戦略
  • 市場ランキング分析
  • 企業評価マトリックス
  • 競合状況・動向

第13章 企業プロファイル

  • 主要企業
    • ALLSCRIPTS HEALTHCARE SOLUTIONS
    • CERNER CORPORATION
    • COTIVITI, INC.(VERSCEND TECHNOLOGIES)
    • CITIUSTECH INC.
    • HEALTH CATALYST
    • CVS HEALTH CORPORATION
    • IBM
    • INOVALON
    • MCKESSON CORPORATION
    • MEDEANALYTICS, INC.
    • OPTUM, INC.
    • ORACLE CORPORATION
    • SAS INSTITUTE INC.
    • SCIO HEALTH ANALYTICS(AN EXL COMPANY)
    • VITREOSHEALTH, INC.
    • WIPRO
  • 他の有力企業
    • FLATIRON
    • APIXIO
    • ENLITIC, INC.
    • KOMODO HEALTH, INC.
    • HEALTHEC, LLC
    • SEMA4
    • EVIDATION HEALTH, INC.
    • INSILICO MEDICINE
    • EXSCIENTIA
    • AETION, INC.

第14章 付録

目次
Product Code: HIT 2180

The healthcare analytics market is projected to reach USD 75.1 billion by 2026 from an estimated USD 21.1 billion in 2021, at a CAGR of 28.9% during the forecasted period.Healthcare analytics is the efficient use of data and related business insights developed through statistical, quantitative, predictive, comparative, cognitive, and other emerging applied analytical models. Healthcare analytics tools help reveal and understand historical data patterns, predict future outcomes, and provide actionable insights to drive fact-based decision-making for improved clinical, financial, and operational performance of healthcare organizations. The use of analytics helps healthcare systems reduce healthcare costs and improve the quality of care. However, high cost related to healthcare analytics software and services and a dearth of skilled professionals are likely to challenge market growth in the coming years.

Cognitive analytics to be the fastest-growing segment in the type market

Based on type, the market is segmented into cognitive analytics, descriptive analytics, predictive analytics, and prescriptive analytics. Cognitive analytics uses artificial intelligence (AI) technologies such as machine learning, deep learning, natural language processing (NLP), and reasoning or logic systems to provide analysis. It automates the decision-making process and provides insights and suggestions to enhance human decisions. The descriptive analytics segment is expected to account for the largest share of 52.3% of the healthcare analytics market in 2021. Descriptive analytics help healthcare payers and providers to better monitor and manage their business practices. It categorizes, characterizes, consolidates, and classifies the past data to convert it into useful information. Most organizations prefer descriptive/retrospective analytics since it can be implemented with the standard aggregate functions built into most databases.

Services segment to hold the largest share of the component market

Based on component, the healthcare analytics market is segmented into services, hardware, and software. The services segment accounted for the largest market share of 51.9% in 2020. The large share of this segment can be attributed to their indispensable nature and repetitive requirement. This is because end users of healthcare analytics rely heavily on service providers for consulting, data storage, implementing services, training, maintenance, and regular solution upgrades.

The US to dominate thehealthcare analytics market in North America

North America dominated the healthcare analytics market, with a share of 61.0% in 2020, followed by Europe and the Asia Pacific. The large share of North America in the global healthcare analytics market can be attributed to the implementation of federal health mandates that encourage the adoption of HCIT solutions, increasing focus on PHM, a significant amount of VC investments, growing pressure to reduce healthcare costs, technological advancements, and high product and service availability in this region. Moreover, most of the leading players in the healthcare analytics market have their headquarters in North America.

Breakdown of supply-side primary interviews: * By Company Type: Tier 1 - 37%, Tier 2 - 22%, and Tier 3 - 41% * By Designation:Director-level - 25%, C-level - 20%, and Others - 55% * By Region: North America - 40%, Europe - 27%, APAC -20%, Rest of the World -13%

Some of the prominent players operating in the healthcare analytics market areIBM (US), Optum (US), Cerner (US), SAS Institute (US), Allscripts (US), McKesson (US), MedeAnalytics (US), Inovalon (US), Oracle (US), Health Catalyst (US), SCIO Health Analytics (US), Cotiviti (formerly Verscend Technologies) (US), CitiusTech (US), Wipro (India), and VitreosHealth (US), Linguamatics (US), Flatiron (US), Roam Analytics (US), Komodo Health (US), CVS Health (US), among others.

Research Coverage

This report studies the healthcare analytics market based on type, application, component, deployment model, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies - source and destination.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.2.2.1 Insights from primary experts
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND- SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION: HEALTHCARE ANALYTICS MARKET
    • FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 7 REVENUE ANALYSIS OF THE TOP THREE PUBLIC COMPANIES: HEALTHCARE ANALYTICS MARKET (2020)
    • FIGURE 8 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF HEALTHCARE ANALYTICS (US)
    • FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE HEALTHCARE ANALYTICS MARKET (2021-2026)
    • FIGURE 11 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: HEALTHCARE ANALYTICS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 HEALTHCARE ANALYTICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE HEALTHCARE ANALYTICS MARKET

4 PREMIUM INSIGHTS

  • 4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
    • FIGURE 19 GOVERNMENT INITIATIVES TO INCREASE EHR ADOPTION AND GROWING PRESSURE TO CURB HEALTHCARE COSTS ARE DRIVING MARKET GROWTH
  • 4.2 FINANCIAL ANALYTICS MARKET SHARE, BY TYPE & REGION (2020)
    • FIGURE 20 NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE FINANCIAL ANALYTICS MARKET IN 2020
  • 4.3 HEALTHCARE ANALYTICS MARKET: GEOGRAPHIC MIX
    • FIGURE 21 THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 4.4 REGIONAL MIX: HEALTHCARE ANALYTICS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Government initiatives to increase EHR adoption
    • FIGURE 24 EHR ADOPTION RATE AMONG HEALTHCARE PROVIDERS IN THE US (2012-2020)
      • 5.2.1.2 Growing venture capital investments
      • 5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes
    • FIGURE 25 HEALTHCARE SPENDING AS A PERCENTAGE OF GDP, BY COUNTRY, 2018
      • 5.2.1.4 Big data in healthcare
      • 5.2.1.5 Growing focus on real-world evidence
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of analytics solutions
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing focus on value-based medicine
      • 5.2.3.2 Use of analytics in precision and personalized medicine
      • 5.2.3.3 Cloud-based analytics
      • 5.2.3.4 Increasing number of patient registries
      • 5.2.3.5 Emergence of social media and its impact on the healthcare industry
      • 5.2.3.6 Augmented analytics
      • 5.2.3.7 Analytics of Healthcare Things
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Patient data confidentiality
      • 5.2.4.2 Concerns regarding inaccurate and inconsistent data
      • 5.2.4.3 Reluctance to adopt healthcare analytics solutions in emerging countries
      • 5.2.4.4 Data integration
      • 5.2.4.5 Operational gaps between payers and providers
      • 5.2.4.6 Dearth of skilled personnel

6 HEALTHCARE ANALYTICS MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 2 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.2 DESCRIPTIVE ANALYTICS
    • 6.2.1 DESCRIPTIVE ANALYTICS IS USED TO CONVERT PAST DATA INTO USEFUL INFORMATION
    • TABLE 3 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 PREDICTIVE ANALYTICS
    • 6.3.1 THE INCREASING INCIDENCE OF HEALTHCARE FRAUD IS DRIVING THE MARKET GROWTH FOR PREDICTIVE ANALYTICS
    • TABLE 4 PREDICTIVE ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 PRESCRIPTIVE ANALYTICS
    • 6.4.1 PRESCRIPTIVE ANALYTICS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    • TABLE 5 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.5 COGNITIVE ANALYTICS
    • 6.5.1 VENDORS ARE NOW FOCUSING ON INTRODUCING AI-DRIVEN ANALYTICS SOLUTIONS
    • TABLE 6 COGNITIVE ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)

7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
    • TABLE 7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
  • 7.2 SERVICES
    • TABLE 8 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 9 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.1 SUPPORT SERVICES
      • 7.2.1.1 Support services include implementation, ongoing IT support, system integration, training, and maintenance services
    • TABLE 10 HEALTHCARE ANALYTICS SUPPORT SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.2 BUSINESS ANALYTICS SERVICES
      • 7.2.2.1 Business analytics services help healthcare organizations to optimize the use of analytics and drive performance improvement
    • TABLE 11 HEALTHCARE BUSINESS ANALYTICS SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 SOFTWARE
    • 7.3.1 HEALTHCARE ANALYTICS SOFTWARE WORKS AS AN INTERFACE BETWEEN THE DATABASE AND END USERS
    • TABLE 12 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 HARDWARE
    • 7.4.1 INCREASING ADOPTION OF CLOUD SERVERS IS EXPECTED TO HINDER THE GROWTH OF THE HARDWARE MARKET FOR ANALYTICS
    • TABLE 13 HEALTHCARE ANALYTICS HARDWARE MARKET, BY REGION, 2019-2026 (USD MILLION)

8 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL

  • 8.1 INTRODUCTION
    • TABLE 14 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
  • 8.2 ON-PREMISE DEPLOYMENT
    • 8.2.1 ON-PREMISE DEPLOYMENT MODELS OFFER MULTIVENDOR ARCHITECTURE, WHICH LOWERS THE RISK OF DATA BREACHES & EXTERNAL ATTACKS
    • TABLE 15 ON-PREMISE SOLUTIONS AVAILABLE IN THE MARKET
    • TABLE 16 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE DEPLOYMENT MODEL, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 ON-DEMAND DEPLOYMENT
    • 8.3.1 INCREASING VOLUME OF DATA GENERATED ACROSS THE HEALTHCARE PROVIDER INDUSTRY TO DRIVE THE ADOPTION OF ON-DEMAND DEPLOYMENT
    • TABLE 17 ON-DEMAND SOLUTIONS AVAILABLE IN THE MARKET
    • TABLE 18 HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND DEPLOYMENT MODEL, BY REGION, 2019-2026 (USD MILLION)

9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 19 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 9.2 FINANCIAL ANALYTICS
    • TABLE 20 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
    • TABLE 21 FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 22 FINANCIAL ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.2.1 CLAIMS PROCESSING
      • 9.2.1.1 Need to improve claims response time and avoid fraudulent claims will support the use of analytics tools
    • TABLE 23 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
    • TABLE 24 CLAIMS PROCESSING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.2.2 REVENUE CYCLE MANAGEMENT
      • 9.2.2.1 Healthcare organizations are rapidly adopting predictive analytics solutions for proactive decision-making
    • TABLE 25 COMMERCIALLY AVAILABLE RCM SOLUTIONS
    • TABLE 26 REVENUE CYCLE MANAGEMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
      • 9.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems will drive market growth
    • TABLE 27 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
    • TABLE 28 PAYMENT INTEGRITY & FWA MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.2.4 RISK ADJUSTMENT & ASSESSMENT
      • 9.2.4.1 Risk adjustment & assessment allow for optimization of cash flows and improved financial performance
    • TABLE 29 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
    • TABLE 30 RISK ADJUSTMENT & ASSESSMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 CLINICAL ANALYTICS
    • TABLE 31 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
    • TABLE 32 CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 33 CLINICAL ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
      • 9.3.1.1 Benchmarking allows for the identification of issues that are negatively impacting healthcare systems
    • TABLE 34 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
    • TABLE 35 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.3.2 CLINICAL DECISION SUPPORT
      • 9.3.2.1 Predictive clinical analytics reduce medical errors and ensure that appropriate tests are performed, a key factor for market growth
    • TABLE 36 COMMERCIALLY AVAILABLE SOLUTIONS FOR CDS
    • TABLE 37 CLINICAL DECISION SUPPORT MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.3.3 REPORTING & COMPLIANCE
      • 9.3.3.1 Stringent regulatory requirements have led to the need for reporting & compliance solutions
    • TABLE 38 REPORTING & COMPLIANCE MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
      • 9.3.4.1 Growing adoption of EHRs to provide significant growth opportunities
    • TABLE 39 COMMERCIALLY AVAILABLE COMPARATIVE ANALYTICS/EFFECTIVENESS SOLUTIONS
    • TABLE 40 COMPARATIVE ANALYTICS/EFFECTIVENESS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.3.5 PRECISION HEALTH
      • 9.3.5.1 Strong government support for personalized medicine is likely to drive market growth
    • TABLE 41 COMMERCIALLY AVAILABLE PRECISION HEALTH SOLUTIONS
    • TABLE 42 PRECISION HEALTH MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.3.6 MEDICAL IMAGING ANALYTICS
      • 9.3.6.1 Imaging analytics aided by artificial intelligence and machine learning is rapidly expanding within the healthcare IT industry
    • TABLE 43 MEDICAL IMAGING ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
    • TABLE 44 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
    • TABLE 45 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 46 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.4.1 SUPPLY CHAIN ANALYTICS
      • 9.4.1.1 The growing requirement to reduce healthcare costs will increase the adoption of supply chain analytics solutions
    • TABLE 47 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
    • TABLE 48 SUPPLY CHAIN ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.4.2 WORKFORCE ANALYTICS
      • 9.4.2.1 Need for real-time resource demand and supply data to drive the adoption of workforce analytics solutions
    • TABLE 49 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
    • TABLE 50 WORKFORCE ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 9.4.3 STRATEGIC ANALYTICS
      • 9.4.3.1 Strategic analytics uses advanced analytics tools to leverage operational and usage data, a key advantage
    • TABLE 51 STRATEGIC ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.5 POPULATION HEALTH ANALYTICS
    • 9.5.1 POPULATION HEALTH ANALYTICS IMPROVES POPULATION HEALTH OUTCOMES AND LOWERS COSTS, A KEY FACTOR FOR MARKET GROWTH
    • TABLE 52 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
    • TABLE 53 POPULATION HEALTH ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)

10 HEALTHCARE ANALYTICS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 54 HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.2 PAYERS
    • TABLE 55 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2019-2026 (USD MILLION)
    • 10.2.1 PRIVATE INSURANCE COMPANIES
      • 10.2.1.1 Private insurance companies accounted for the largest share of the payers market in 2020
    • TABLE 57 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES, BY REGION, 2019-2026 (USD MILLION)
    • 10.2.2 GOVERNMENT AGENCIES
      • 10.2.2.1 Increasing use of analytics solutions by government agencies to boost the market growth of this end-user segment
    • TABLE 58 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT AGENCIES, BY REGION, 2019-2026 (USD MILLION)
    • 10.2.3 EMPLOYERS AND PRIVATE EXCHANGES
      • 10.2.3.1 Private exchanges and employers use data analytics for rapid data integration, health plan analysis, and risk modeling
    • TABLE 59 HEALTHCARE ANALYTICS MARKET FOR EMPLOYERS AND PRIVATE EXCHANGES, BY REGION, 2019-2026 (USD MILLION)
  • 10.3 PROVIDERS
    • TABLE 60 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
      • 10.3.1.1 The adoption of healthcare analytics solutions is the highest in large hospitals
    • TABLE 61 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS, PHYSICIAN PRACTICES, AND IDNS, BY REGION, 2019-2026 (USD MILLION)
    • 10.3.2 POST-ACUTE CARE ORGANIZATIONS (PACOS)
      • 10.3.2.1 PACOs focus on reviewing and studying patient data with the help of healthcare analytics
    • TABLE 62 HEALTHCARE ANALYTICS MARKET FOR PACOS, BY REGION, 2019-2026 (USD MILLION)
    • 10.3.3 AMBULATORY SETTINGS
      • 10.3.3.1 The need to control healthcare costs to support the market growth of ambulatory settings
    • TABLE 63 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SETTINGS, BY REGION, 2019-2026 (USD MILLION)
  • 10.4 ACOS, HIES, MCOS, AND TPAS
    • TABLE 64 HEALTHCARE ANALYTICS MARKET FOR ACOS, HIES, MCOS, AND TPAS, BY REGION, 2019-2026 (USD MILLION)

11 HEALTHCARE ANALYTICS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 65 HEALTHCARE ANALYTICS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 26 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2020)
    • TABLE 66 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 67 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 68 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 69 NORTH AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 NORTH AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 71 NORTH AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 72 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 73 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 74 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 75 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 76 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 77 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 High adoption of EHRs to drive the healthcare analytics market in the US
    • TABLE 78 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 79 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 80 US: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 81 US: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 US: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 83 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 84 US: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 US: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 86 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 87 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Need for managing patient volumes, clinical data, and healthcare costs will favor market growth in Canada
    • TABLE 89 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 90 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 91 CANADA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 CANADA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 93 CANADA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 95 CANADA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 CANADA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 97 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 98 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
  • 11.3 EUROPE
    • FIGURE 27 EUROPE: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2020)
    • TABLE 100 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 101 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 103 EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 106 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 107 EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 108 EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 109 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 110 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 111 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Government initiatives to increase the use of analytics in healthcare are expected to contribute to market growth in Germany
    • TABLE 112 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 113 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 114 GERMANY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 115 GERMANY: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 GERMANY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 118 GERMANY: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 GERMANY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 120 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 121 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 122 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 Availability of venture capital investments to drive market growth in the UK
    • TABLE 123 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 125 UK: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 UK: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 127 UK: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 128 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 129 UK: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 UK: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 131 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 132 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 133 UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Strong financial support for digital health contributes to the growth in the healthcare analytics market in France
    • TABLE 134 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 135 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 136 FRANCE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 137 FRANCE: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 138 FRANCE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 140 FRANCE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 FRANCE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 142 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 143 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.3.4 REST OF EUROPE
    • TABLE 145 ROE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 146 ROE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 147 ROE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 148 ROE: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 149 ROE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 ROE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 151 ROE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 ROE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 153 ROE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 154 ROE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 155 ROE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
  • 11.4 ASIA
    • FIGURE 28 ASIA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2020)
    • TABLE 156 ASIA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 157 ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 159 ASIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 ASIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 161 ASIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 162 ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 163 ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 164 ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 165 ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 166 ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Rise in the geriatric population will increase the demand for effective patient management solutions
    • TABLE 168 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 169 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 170 JAPAN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 JAPAN: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 172 JAPAN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 173 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 174 JAPAN: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 175 JAPAN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 176 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 177 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Favorable reforms and a growing number of EHRs have contributed to market growth in China
    • TABLE 179 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 180 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 181 CHINA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 182 CHINA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 183 CHINA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 184 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 185 CHINA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 186 CHINA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 187 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 188 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 189 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 The HCIT market in India is still in the nascent stage
    • TABLE 190 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 191 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 192 INDIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 193 INDIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 194 INDIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 196 INDIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 197 INDIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 198 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 199 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 200 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
    • 11.4.4 REST OF ASIA
    • TABLE 201 ROA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 202 ROA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 203 ROA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 204 ROA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 205 ROA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 206 ROA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 207 ROA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 208 ROA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 209 ROA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 210 ROA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 211 ROA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
  • 11.5 PACIFIC COUNTRIES
    • 11.5.1 NEED TO REDUCE HEALTHCARE COSTS IN AUSTRALIA AND NEW ZEALAND TO DRIVE MARKET GROWTH IN THIS REGION
    • TABLE 212 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 213 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 214 PACIFIC COUNTRIES: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 215 PACIFIC COUNTRIES: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 216 PACIFIC COUNTRIES: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 217 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 218 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 219 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 220 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 221 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 222 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
  • 11.6 LATIN AMERICA
    • 11.6.1 GROWING EHEALTH INITIATIVES IN LATAM COUNTRIES TO DRIVE MARKET GROWTH IN THIS REGION
    • TABLE 223 LATAM: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 224 LATAM: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 225 LATAM: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 226 LATAM: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 227 LATAM: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 228 LATAM: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 229 LATAM: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 230 LATAM: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 231 LATAM: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 232 LATAM: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 233 LATAM: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)
  • 11.7 MIDDLE EAST & AFRICA
    • 11.7.1 HIGH HEALTHCARE EXPENDITURE AND INFRASTRUCTURAL DEVELOPMENT WILL SUPPORT THE USE OF HCIT SOLUTIONS IN THE MIDDLE EAST
    • TABLE 234 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 235 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 236 MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 237 MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 238 MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 239 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 240 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 241 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019-2026 (USD MILLION)
    • TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ANALYTICS MARKET
  • 12.3 MARKET RANKING ANALYSIS
    • FIGURE 29 IBM WAS THE LEADING PLAYER IN THE HEALTHCARE ANALYTICS MARKET IN 2020
  • 12.4 COMPANY EVALUATION MATRIX
    • 12.4.1 COMPANY EVALUATION MATRIX: HEALTHCARE ANALYTICS MARKET
      • 12.4.1.1 Stars
      • 12.4.1.2 Pervasive players
      • 12.4.1.3 Emerging leaders
      • 12.4.1.4 Participants
      • 12.4.1.5 Competitive benchmarking
        • 12.4.1.5.1 Overall footprint of companies (20 companies)
    • TABLE 245 SERVICE FOOTPRINT OF COMPANIES (20 COMPANIES)
    • TABLE 246 END-USER FOOTPRINT OF COMPANIES (20 COMPANIES)
    • TABLE 247 REGIONAL FOOTPRINT OF COMPANIES (20 COMPANIES)
  • 12.5 COMPETITIVE SITUATIONS AND TRENDS
    • 12.5.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
    • TABLE 248 PRODUCT/SERVICE LAUNCHES (JANUARY 2018 TO AUGUST 2021)
    • 12.5.2 DEALS
    • TABLE 249 DEALS (JANUARY 2018 TO AUGUST 2021)

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 13.1.1 ALLSCRIPTS HEALTHCARE SOLUTIONS
    • TABLE 250 ALLSCRIPTS HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW
    • FIGURE 31 ALLSCRIPTS HEALTHCARE SOLUTIONS: COMPANY SNAPSHOT (2020)
    • 13.1.2 CERNER CORPORATION
    • TABLE 251 CERNER CORPORATION: BUSINESS OVERVIEW
    • 13.1.3 COTIVITI, INC. (VERSCEND TECHNOLOGIES)
    • TABLE 252 COTIVITI, INC.: BUSINESS OVERVIEW
    • 13.1.4 CITIUSTECH INC.
    • TABLE 253 CITIUSTECH INC.: BUSINESS OVERVIEW
    • 13.1.5 HEALTH CATALYST
    • TABLE 254 HEALTH CATALYST: BUSINESS OVERVIEW
    • 13.1.6 CVS HEALTH CORPORATION
    • TABLE 255 CVS HEALTH CORPORATION: BUSINESS OVERVIEW
    • 13.1.7 IBM
    • TABLE 256 IBM: BUSINESS OVERVIEW
    • 13.1.8 INOVALON
    • TABLE 257 INOVALON: BUSINESS OVERVIEW
    • FIGURE 35 INOVALON: COMPANY SNAPSHOT (2020)
    • 13.1.9 MCKESSON CORPORATION
    • TABLE 258 MCKESSON CORPORATION: BUSINESS OVERVIEW
    • 13.1.10 MEDEANALYTICS, INC.
    • TABLE 259 MEDEANALYTICS, INC.: BUSINESS OVERVIEW
    • 13.1.11 OPTUM, INC.
    • TABLE 260 OPTUM, INC.: BUSINESS OVERVIEW
    • 13.1.12 ORACLE CORPORATION
    • TABLE 261 ORACLE CORPORATION: BUSINESS OVERVIEW
    • 13.1.13 SAS INSTITUTE INC.
    • TABLE 262 SAS INSTITUTE INC.: BUSINESS OVERVIEW
    • 13.1.14 SCIO HEALTH ANALYTICS (AN EXL COMPANY)
    • TABLE 263 SCIO HEALTH ANALYTICS: BUSINESS OVERVIEW
    • 13.1.15 VITREOSHEALTH, INC.
    • TABLE 264 VITROSHEALTH, INC.: BUSINESS OVERVIEW
    • 13.1.16 WIPRO
    • TABLE 265 WIPRO: BUSINESS OVERVIEW
    • FIGURE 40 WIPRO: COMPANY SNAPSHOT (2020)
  • 13.2 OTHER PLAYERS
    • 13.2.1 FLATIRON
    • TABLE 266 FLATIRON: BUSINESS OVERVIEW
    • 13.2.2 APIXIO
    • TABLE 267 APIXIO: BUSINESS OVERVIEW
    • 13.2.3 ENLITIC, INC.
    • TABLE 268 ENLITIC, INC.: BUSINESS OVERVIEW
    • 13.2.4 KOMODO HEALTH, INC.
    • TABLE 269 KOMODO HEALTH, INC.: BUSINESS OVERVIEW
    • 13.2.5 HEALTHEC, LLC
    • TABLE 270 HEALTHEC, LLC: BUSINESS OVERVIEW
    • 13.2.6 SEMA4
    • 13.2.7 EVIDATION HEALTH, INC.
    • 13.2.8 INSILICO MEDICINE
    • 13.2.9 EXSCIENTIA
    • 13.2.10 AETION, INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS